Targeted inhibition of osteosarcoma tumor growth by bone marrow‐derived mesenchymal stem cells expressing cytosine deaminase/5‐fluorocytosine in tumor‐bearing mice
ConclusionsTaken together, these findings suggest that CD/5‐FC MSCs may be suitable for targeting human osteosarcoma. This article is protected by copyright. All rights reserved.
Source: The Journal of Gene Medicine - Category: Genetics & Stem Cells Authors: Quynh‐Anh NguyenThai, Neelesh Sharma, Do Huynh Luong, Simrinder Singh Sodhi, Jeong‐Hyun Kim, Nameun Kim, Sung‐Jong Oh, Dong‐Kee Jeong Tags: Research Article Source Type: research
More News: Bone Cancers | Cancer | Cancer & Oncology | Cancer Therapy | Genetics | Osteosarcoma | Stem Cell Therapy | Stem Cells | Study